Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06939751 · ClinicalTrials.gov registry record

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

A clinical trial of Graft Rejection and Cardiac Failure, sponsored by Inova Health Care Services.

Recruiting
Registry status
250
Enrollment target
5
Study locations

NCT06939751 is a study of Graft Rejection and Cardiac Failure that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 250 participants, below the 438-participant average among 5 other Graft Rejection trials with a reported enrollment target (43% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06939751, a study of Graft Rejection and Cardiac Failure, is actively recruiting participants, sponsored by Inova Health Care Services.

RECRUITING
Registry status
250 participants
Enrollment target
5
Study locations

Study Summary

This study aims to develop and refine a microRNA (miR) biomarker panel that can be used to phenotype net immune state after heart transplantation using circulating miRs (associated with drug doses and levels). These miRs will be used to characterize the overall immune state in adult heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulation.

Conditions Studied

Graft Rejection Cardiac Failure

Study Locations (5)

California

  • Stanford University - Palo Alto

South Carolina

  • Medical University of South Carolina - Charleston

Tennessee

  • Vanderbilt University - Nashville

Texas

  • Baylor University Medical Center - Dallas

Virginia

  • Inova Health System - Falls Church

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-10-28
Est. Completion 2032-01-01

Sponsor

Inova Health Care Services

75 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06939751

The ClinicalTrials.gov registry entry for NCT06939751 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 438-participant average among 5 other Graft Rejection trials with a reported enrollment target (43% lower). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Graft Rejection appearing as the primary indexed condition, and to 0 interventions.

NCT06939751 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, South Carolina, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06939751 about?

NCT06939751 is a clinical study titled "OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels". This study aims to develop and refine a microRNA (miR) biomarker panel that can be used to phenotype net immune state after heart transplantation using circulating miRs (associated with drug doses and levels). These miRs will be used to characterize the overall immune state in adult heart transplant...

What is the current status of trial NCT06939751?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-10-28. Estimated completion is 2032-01-01.

What conditions does trial NCT06939751 study?

This clinical trial studies the following conditions: Graft Rejection, Cardiac Failure.

Who is sponsoring clinical trial NCT06939751?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06939751 being conducted?

This trial has 5 study locations across California, South Carolina, Tennessee, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Graft Rejection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Graft Rejection

All registered trials for this condition

Cardiac Failure

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.